Perhaps surprisingly, universities are worse at publishing clinical trial results than pharmaceutical companies. Universities have different motivations for not publishing the results of clinical trials than pharmaceutical companies. Because of this their pattern of non-publication is different. The ratio of non-reported negative to positive clinical trials is 2:1 for the pharmaceutical industry, but more random for universities.
